救急医療のための新型コロナウイルス感染症COVID-19診療ガイド

出版社: 総合医学社
著者:
発行日: 2020-07-15
分野: 臨床医学:一般  >  救命/救急
ISBN: 9784883787128
電子書籍版: 2020-07-15 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:約3営業日

2,420 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,420 円(税込)

商品紹介

コロナウイルス診療の最新ネット情報へアクセスするための一冊!
QRコードで,簡単にアクセス出来ます!
「コロナウイルス診療に関する主要情報一覧」を巻末に掲載!

目次

  • ・本稿について
    ・要 点
    ・症例提示
    ・序 章
    ・文献の批判的吟味
    ・疫 学
    ・北イタリアにおけるCOVID-19:得た教訓
    ・ウイルス学
    ・病態生理学
    ・免疫原性(サイトカインストーム)
    ・ACE阻害薬,ARBs,NSAIDs
    ・予防(流行曲線をゆるやかにする)
    ・感染コントロール
    ・個人防護具の使用
    ・救急外来での評価と診断
    ・臨床的特徴
    ・SARS CoV-2検査
      合併感染症の検査
      検査マーカーと患者特性
    ・画像検査
    ・マネジメント
    ・抗ウイルス薬
    ・グルココルチコイド
    ・その他の治療薬
    ・輸液管理
    ・気道管理
    ・非侵襲的換気療法
    ・侵襲的換気療法のためのRSI
      前酸素化
    ・侵襲的換気療法戦略
    ・災害レベル時の換気療法
    ・小 児
    ・妊 婦
    ・未来への展望
    ・病院管理
    ・症例の顛末

    【追加情報】
    ・覚醒しているCOVID-19患者の腹臥位-(4/8/20)
    ・COVID-19流行中の喘息患者の治療プロトコール-(4/7/20)

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

要点

P.3 掲載の参考文献
1. Johns Hopkins University Center for Systems Science and Engineering. "Coronavirus COVID-19 global cases by Johns Hopkins CSSE." Accessed February 6, 2020. (Johns Hopkins epidemiologic tracking website)

序章

P.5 掲載の参考文献

疫学

P.7 掲載の参考文献
P.8 掲載の参考文献

ウイルス学

P.13 掲載の参考文献
P.14 掲載の参考文献

病態生理学

P.15 掲載の参考文献

免疫原性 ( サイトカインストーム )

P.16 掲載の参考文献
20. Chen C, Zhang XR, Ju ZY, et al. [Advances in the research of cytokine storm mechanism induced by corona virus disease 2019 and the corresponding immunotherapies]. Zhonghua Shao Shang Za Zhi 2020 ; 36 : E005-E005 (Basic science review).
22. Yonggang Zhou BF, Xiaohu Zheng et al. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. 2020. Accessed March 22, 2020.
P.17 掲載の参考文献
24. Mehta P, McAuley DF, Brown M, et al. COVID-19 : consider cytokine storm syndromes and immunosuppression. The Lancet.
27. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study. Lancet (London, England) 2020 : S0140-6736 (0120) 30566-30563 (Retrospective cohort study ; 191 patients).

ACE阻害薬, ARBs, NSAIDs

P.18 掲載の参考文献
28. European Society of Cardiology. "Position statement of he ESC Council on hypertension on ACE-inhibitors and angiotensin receptor blockers. " 2020 ; Accessed March 17, 2020. (Position statement)
29. American College of Cardiology. HFSA/ACC/AHA statement addresses concerns re : using RAAS antagonists in COVID-19. 2020 Accessed March 20, 2020. (ACC statement)

予防 ( 流行曲線をゆるやかにする )

P.19 掲載の参考文献
30. Kucharski AJ, Russell TW, Diamond C, et al. Early dynamics of transmission and control of COVID-19 : a mathematical modelling study. Lancet Infect Dis 2020 : S1473-3099 (1420) 30144-30144 (Epidemiological mathematic modeling study).
31. Fang Y, Nie Y, Penny M. Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions : a data-driven analysis. J Med Virol (Epidemiological mathematic modeling study).
32. Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. The Lancet Global Health.
P.20 掲載の参考文献
33. Ferguson NM, Laydon D, Nedjati-Gilani G, Imperial College COVID-19 Response Team, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. 2020 Accessed : March 22, 2020.
34. Remuzzi A, Remuzzi G. COVID-19 and Italy : what next? Lancet. (Health policy editorial).

感染コントロール

P.21 掲載の参考文献
36. Lesney M. "WHO Urges That 'Window of Opportunity' on Containing Novel Coronavirus Not Be Missed. " Medscape Medical News. Accessed February 20, 2020. (Medical news site)
37. CNBC Live. "World Health Organization holds a news conference on the coronavirus outbreak, 2/21/20. ".
P.22 掲載の参考文献
5. United States Centers for Disease Control and Prevention. "2019 Novel Coronavirus (COVID-19). " 2020 ; Accessed March 22, 2020. (CDC website)
39. Jin Y-H, Cai L, Cheng Z-S, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research 2020 ; 7 (1) : 4 (Clinical practice guidelines-US).
41. Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020 Feb 28 [Epub ahead of print] (Retrospective cohort analysis ; 1099 patients).

個人防護具の使用

P.23 掲載の参考文献
42. Farkas J. "When to transition from HFNC to intubation (when to determine that the patient has 'failed' HFNC). " Accessed March 16, 2020. (Website)

P.24 掲載の参考文献
P.26 掲載の参考文献

SARS CoV - 2検査

P.27 掲載の参考文献
47. United States Centers for Disease Control and Prevention. "IRR (International Reagent Resource). " Accessed February 20, 2020. (CDC website)
48. United States Centers for Disease Control and Prevention. "CDC Tests for COVID-19. " Accessed February 20, 2020. (CDC website)
49. Legacy Health. "Respiratory Panel by PCR. " Accessed February 20, 2020. (Healthcare provider website)
P.28 掲載の参考文献
P.29 掲載の参考文献
52. Wang M, Wu Q, Xu W, et al. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. medRxiv [Preprint] (Non-peer reviewed research, preprint).
53. Shah N. "Higher co-infection rates in COVID19. " 2020 ; Accessed March 18, 2020. (Website post)
P.30 掲載の参考文献
27. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study. Lancet (London, England) 2020 : S0140-6736 (0120) 30566-30563 (Retrospective cohort study ; 191 patients).
P.31 掲載の参考文献

画像検査

P.33 掲載の参考文献
59. Li YM, Wang SX, Gao HS, et al. [Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence]. Zhonghua Yi Xue Za Zhi 2004 ; 84 (16) : 1348-1353 (Retrospective study ; 40 patients).
60. Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 200230 (Retrospective study ; 21 patients).
P.34 掲載の参考文献
62. American College of Radiology. ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection. 2020. Accessed March 22, 2020. (ACR recommedations)
P.35 掲載の参考文献
P.37 掲載の参考文献
39. Jin Y-H, Cai L, Cheng Z-S, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research 2020 ; 7 (1) : 4 (Clinical practice guidelines-US).
P.38 掲載の参考文献

マネジメント

P.39 掲載の参考文献

抗ウイルス薬

P.41 掲載の参考文献
39. Jin Y-H, Cai L, Cheng Z-S, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research 2020 ; 7 (1) : 4 (Clinical practice guidelines-US).
67. Jiang H, Deng H, Wang Y, et al. The possibility of using lopinavir/litonawe (LPV/r) as treatment for novel coronavirus COVID-19 pneumonia : a quick systematic review based on earlier coronavirus clinical studies. Zhonghua Jizhen Yixue Zazhi2020 ; 29 (2) : 182-186 (Systematic review of Chinese literature on antivirals in SARS-CoV and MERS-CoV).
68. Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020 Mar 18 [Epub ahead of print].
P.42 掲載の参考文献
P.43 掲載の参考文献
73. Cai Q, Yang M, Liu D, et al. Experimental treatment with favipiravir for COVID-19 : an open-label control study. Engineering Available online 18 March 2020 (In-press ; journal pre-proof ; open-label nonrandomized control study ; 35 patients in treatment arm, 45 patients in control arm).

グルココルチコイド

P.44 掲載の参考文献
45. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020 Mar 13 [Epub ahead of print] (Retrospective cohort study ; 201 patients).
59. Li YM, Wang SX, Gao HS, et al. [Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence]. Zhonghua Yi Xue Za Zhi 2004 ; 84 (16) : 1348-1353 (Retrospective study ; 40 patients).
74. Xiao JZ, Ma L, Gao J, et al. [Glucocorticoid-induced diabetes in severe acute respiratory syndrome : the impact of high dosage and duration of methylprednisolone therapy]. Zhonghua Nei Ke Za Zhi 2004 ; 43 (3) : 179-182 (Retrospective study ; 133 patients).

その他の治療薬

P.45 掲載の参考文献
P.46 掲載の参考文献

気道管理

P.48 掲載の参考文献
39. Jin Y-H, Cai L, Cheng Z-S, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research 2020 ; 7 (1) : 4 (Clinical practice guidelines-US).

非侵襲的換気療法

P.49 掲載の参考文献
45. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020 Mar 13 [Epub ahead of print] (Retrospective cohort study ; 201 patients).

侵襲的換気療法戦略

P.53 掲載の参考文献

災害レベル時の換気療法

P.54 掲載の参考文献
https://www.youtube.com/watch?v=uClq978oohY

小児

P.55 掲載の参考文献
P.56 掲載の参考文献

妊婦

P.58 掲載の参考文献

未来への展望

P.59 掲載の参考文献
P.60 掲載の参考文献

病院管理

P.61 掲載の参考文献
94. United States Centers for Disease Control and Prevention. "Coronavirus disease 2019 (COVID-19) hospital preparedness assessment tool." Accessed March 22, 2020. (CDC website)

最近チェックした商品履歴

Loading...